Acorn Creek Capital LLC trimmed its position in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 18.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,644 shares of the company’s stock after selling 365 shares during the period. Acorn Creek Capital LLC’s holdings in Procter & Gamble were worth $262,000 at the end of the most recent quarter.
A number of other large investors have also bought and sold shares of PG. Kingstone Capital Partners Texas LLC increased its stake in Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after purchasing an additional 76,017,350 shares in the last quarter. Nuveen LLC bought a new stake in Procter & Gamble during the 1st quarter worth approximately $1,954,941,000. Price T Rowe Associates Inc. MD increased its stake in Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after purchasing an additional 2,466,308 shares in the last quarter. Invesco Ltd. increased its stake in Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock worth $2,299,580,000 after purchasing an additional 2,228,151 shares in the last quarter. Finally, Valeo Financial Advisors LLC grew its stake in shares of Procter & Gamble by 1,875.5% during the 2nd quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock worth $280,946,000 after acquiring an additional 1,674,139 shares in the last quarter. 65.77% of the stock is owned by institutional investors.
Insider Buying and Selling
In other Procter & Gamble news, insider Marc S. Pritchard sold 9,849 shares of Procter & Gamble stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,548,952.23. Following the transaction, the insider owned 182,422 shares in the company, valued at $28,689,507.94. The trade was a 5.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Gary A. Coombe sold 10,194 shares of Procter & Gamble stock in a transaction dated Thursday, August 21st. The shares were sold at an average price of $158.16, for a total value of $1,612,283.04. Following the completion of the transaction, the chief executive officer owned 34,978 shares in the company, valued at approximately $5,532,120.48. This represents a 22.57% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 149,763 shares of company stock valued at $23,421,279 in the last ninety days. Insiders own 0.20% of the company’s stock.
Procter & Gamble Stock Down 0.6%
Procter & Gamble (NYSE:PG – Get Free Report) last posted its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. During the same quarter last year, the firm earned $1.40 earnings per share. The company’s revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities analysts expect that Procter & Gamble Company will post 6.91 EPS for the current year.
Wall Street Analyst Weigh In
PG has been the subject of several research reports. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Procter & Gamble in a research note on Wednesday, October 8th. Barclays decreased their target price on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 1st. Evercore ISI reissued an “in-line” rating and issued a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Berenberg Bank raised their price target on Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a report on Wednesday, September 17th. Finally, JPMorgan Chase & Co. cut their price target on Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating for the company in a report on Friday. Eleven equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $172.21.
View Our Latest Research Report on PG
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
- Five stocks we like better than Procter & Gamble
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Microsoft 365 Premium Marks the Next Phase of AI Monetization
- What Makes a Stock a Good Dividend Stock?
- Could Target’s Week of Discounts Come Full Circle for Investors?
- Want to Profit on the Downtrend? Downtrends, Explained.
- 3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.